What Percent Of Our Genetic Makeup Similar To Others

Although there are many possible causes of homo affliction, family history is often 1 of the strongest risk factors for common disease complexes such equally cancer, cardiovascular affliction (CVD), diabetes, autoimmune disorders, and psychiatric illnesses. A person inherits a complete ready of genes from each parent, too equally a vast array of cultural and socioeconomic experiences from his/her family unit. Family history is idea to exist a good predictor of an individual's affliction risk considering family members near closely represent the unique genomic and environmental interactions that an private experiences (Kardia et al., 2003). Inherited genetic variation within families conspicuously contributes both direct and indirectly to the pathogenesis of affliction. This chapter focuses on what is known or theorized virtually the direct link between genes and health and what still must exist explored in order to understand the environmental interactions and relative roles amongst genes that contribute to health and illness.

GENETIC SUSCEPTIBILITY

For more than 100 years, homo geneticists have been studying how variations in genes contribute to variations in affliction take chances. These studies have taken ii approaches. The get-go arroyo focuses on identifying the individual genes with variations that give rise to simple Mendelian patterns of affliction inheritance (e.chiliad., autosomal dominant, autosomal recessive, and X-linked) (see Tabular array three-i; Mendelian Inheritance in Homo). The second approach seeks to empathise the genetic susceptibility to disease every bit the con sequence of the joint effects of many genes. Each of these approaches will be discussed beneath.

TABLE three-1

Online Mendelian Inheritance in Human being (OMIM) Statistics (as of May 15, 2006), Number of Entries.

In general, diseases with unproblematic Mendelian patterns of inheritance tend to be relatively uncommon or frequently rare, with early ages of onset, such equally phenylketonuria, sickle jail cell anemia, Tay-Sachs affliction, and cystic fibrosis. In add-on, some of these genes take been associated with farthermost forms of common diseases, such equally familial hypercholesterolemia, which is caused by mutations in the depression-density lipoprotein (LDL) receptor that predispose individuals to early on onset of eye disease (Brown and Goldstein, 1981).

Some other example of Mendelian inheritance is familial forms of breast cancer associated with mutations in the BRCA1 and BRCA2 genes that predispose women to early onset chest cancer and ofttimes ovarian cancer. The genes identified have mutations that oft are highly penetrant—that is, the probability of developing the disease in someone conveying the disease susceptibility genotype is relatively high (greater than l percent). These genetic diseases ofttimes exhibit a genetic phenomenon known as allelic heterogeneity, in which multiple mutations inside the same cistron (i.e., alleles) are plant to be associated with the same disease. This allelic heterogeneity oftentimes is population specific and can stand for the unique demographic and mutational history of the population.

In some cases, genetic diseases also are associated with locus heterogeneity, meaning that a deleterious mutation in any one of several genes can give rising to an increased run a risk of the disease. This is a finding common to many human diseases including Alzheimer's disease and polycystic kidney disease. Both allelic heterogeneity and locus heterogeneity are sources of variation in these affliction phenotypes since they can have varying effects on the affliction initiation, progression, and clinical severity.

Ecology factors also vary across individuals and the combined effect of ecology and genetic heterogeneity is etiologic heterogeneity. Etiologic heterogeneity refers to a miracle that occurs in the general population when multiple groups of illness cases, such every bit breast cancer clusters, exhibit similar clinical features, but are in fact the result of differing events or exposures. Insight into the etiology of specific diseases too as identification of possible causative agents is facilitated by discovery and examination of disease cases demonstrating etiologic heterogeneity. The results of these studies may also highlight possible cistron-factor interactions and gene-surroundings interactions of import in the disease process. Identifying etiologic heterogeneity tin can be an important step toward analysis of diseases using molecular epidemiology techniques and may eventually pb to improved disease prevention strategies (Rebbeck et al., 1997).

As opposed to the Mendelian arroyo, the second arroyo to studying how variations in genes contribute to variations in disease risk focuses on understanding the genetic susceptibility to diseases as the consequence of the joint effects of many genes, each with modest to moderate furnishings (i.east., polygenic models of affliction) and frequently interacting amongst themselves and with the surroundings to requite ascension to the distribution of disease risk seen in a population (i.eastward., multifactorial models of disease). This arroyo has been used primarily for agreement the genetics of birth defects and mutual diseases and their take a chance factors. As described beneath, several steps are involved in developing such an understanding.

As a first step, study participants are asked to provide a detailed family unit history to assess the presence of familial aggregation. If individuals with the disease in question have more relatives affected by the disease than individuals without the disease, familial aggregation is identified. While familial assemblage may be accounted for through genetic etiology, it may also represent an exposure (e.g., pesticides, contaminated drinking water, or diet) common to all family members due to the likelihood of shared environs.

When there is evidence of familial aggregation, the second step is to focus research studies on estimating the heritability of the disease and/or its take chances factors. Heritability is defined as the proportion of variation in affliction risk in a population that is attributable to unmeasured genetic variations inferred through familial patterns of disease. Information technology is a broad population-based measure of genetic influence that is used to determine whether further genetic studies are warranted, since it allows investigators to test the overarching null hypothesis that no genes are involved in determining disease risk. Twin studies and family studies are frequently used in the study of heritability.

Twin studies comparing the affliction and risk cistron variability of monozygotic and dizygotic twins accept been a common study design used to easily estimate both genetic and cultural inheritance. Studies of monozygotic twins reared together versus those reared autonomously also have been important in estimating both genetic and ecology contributions to patterns of inheritance. The modeling of the sources of phenotypic variation using family studies has become quite sophisticated, allowing the inclusion of model parameters to stand for the condiment genetic component (i.e., polygenes), the nonadditive genetic component (i.eastward., genetic authorisation, as well as gene-environment and gene-cistron interactions), shared family environment, and individual environments. The contributions of these factors have been shown to vary by age and population.

When significant evidence of genetic involvement is established, the next stride is to identify the responsible genes and the mutations that are associated with increased or decreased risk, using either genetic linkage assay or genetic association studies. For example, in the written report of nascency defects, this frequently involves the search for chromosomal deletions, insertions, duplications, or translocations.

GENETIC LINKAGE Analysis AND GENETIC Clan STUDIES

The human genome is fabricated upward of tens of thousands of genes. With approximately 30,000 genes to choose from, assigning a specific gene or grouping of genes to a corresponding human being disease demands a methodical approach consisting of many steps. Traditionally, the procedure of gene discovery begins with a linkage analysis that assesses disease within families. Linkage analyses are typically followed by genetic association studies that assess disease across families or across unrelated individuals.

Genetic Linkage Analysis

The term linkage refers to the trend of genes proximally located on the same chromosome to exist inherited together. Linkage analysis is ane step in the search for a illness susceptibility gene. The goal of this analysis is to approximate the location of the disease factor in relation to a known genetic marker, applying an understanding of the patterns of linkage. Traditional linkage analysis that traces patterns of heredity of both the disease phenotype and genetic markers in big, high-take chances families take been used to locate illness-causing gene mutations such as the chest cancer factor (BRCA1) on chromosome 17 (Hall et al., 1990).

Because the mode of inheritance is often not articulate for common diseases, an alternative arroyo to archetype linkage assay was adult to capitalize on the bones genetic principle that siblings share half of their alleles on average. By investigating the degree of allelic sharing across their genomes, pairs of affected siblings (i.e., two or more than siblings with the aforementioned disease) can be used to identify chromosomal regions that may contain genes whose variations are related to the illness existence studied. If numerous sibling pairs affected by the disease of interest exhibit a greater than expected sharing of the known alleles of the polymorphic genetic marker being used, then the genetic marking is likely to be linked (that is, within close proximity forth the chromosome) to the susceptibility cistron responsible for the disease beingness studied. To discover chromosomal regions that show evidence for linkage using this affected sibling pair method typically requires typing numerous affected sibships with hundreds of highly polymorphic markers uniformly positioned along the human genome (Mathew, 2001).

This approach has been widely used to identify regions of the genome idea to contribute to common chronic diseases. However, results of linkage analyses have non been consistently replicated. The inability to successfully replicate linkage findings may be a event of bereft statistical power (that is, including an inadequate number of sibling pairs with the disease of involvement) or results that included false positives in the original study. An alternate caption could be that different populations are affected past different susceptibility genes than those that were studied originally (Mathew, 2001). Without consistent replication of results information technology is premature to depict conclusions about the contribution of a gene locus to a specific disease.

Upon the confirmation of a linkage, researchers tin begin to search the region for the candidate susceptibility gene. The search for a single susceptibility factor for common diseases often involves exam of very large linkage regions, containing 20 to 30 million base pairs and potentially hundreds of genes (Mathew, 2001). It is too important to note, however, that while linkage mapping is a powerful tool for finding Mendelian disease genes, it often produces weak and sometimes inconsistent signals in studies of circuitous diseases that may be multifactorial. Linkage studies perform best when there is a single susceptibility allele at whatsoever given disease locus and generally performs poorly when there is substantial genetic heterogeneity.

Genetic Association Studies

Technological advances in high-throughput genotyping have allowed the direct examination of specific genetic differences among sizable numbers of people. Genetic clan techniques are often the near efficient approach for assessing how specific genetic variation tin can affect disease run a risk. Genetic association studies, which accept been used for decades, have perpetually progressed in terms of the development of new written report designs (such as case-only and family unit-based association designs), new genotyping systems (such as array-based genotyping and multiplexing assays), and new methods used for addressing biases such as population (Haines and Pericak-Vance, 1998).

Assay of the furnishings of genetic variation typically involves first the discovery of single nucleotide polymorphisms (SNPs)^one and then the assay of these variations in samples from populations. SNPs occur on average approximately every 500 to 2,000 bases in the human genome. The well-nigh common approach to SNP discovery is to sequence the cistron of interest in a representative sample of individuals. Currently, sequencing of entire genes on pocket-sized numbers of individuals (~25 to fifty) can notice polymorphisms occurring in 1 to 3 per centum of the population with approximately 95 percentage confidence. The Man DNA Polymorphism Discovery Program of the National Institute of Environmental Wellness Sciences' Environmental Genome Project is i example of the application of automated DNA sequencing technologies to identify SNPs in homo genes that may be associated with affliction susceptibility and response to environment (Livingston et al., 2004). The National Eye, Lung, and Claret Plant'due south Programs in Genomic Applications also has led to of import increases in our cognition virtually the distribution of SNPs in key genes idea to be already biologically implicated in disease risk (i.due east., biological candidate genesⁱⁱ).

Impressive and rapid advances in SNP analysis technology are apace redefining the telescopic of SNP discovery, mapping, and genotyping. New assortment-based genotyping technology enables "whole genome association" analyses of SNPs between individuals or between strains of laboratory animal species (Syvanen, 2005). Arrays used for these analyses can represent hundreds of thousands of SNPs mapped across a genome (Klein et al., 2005; Hinds et al., 2005; Gunderson et al., 2005). This arroyo allows rapid identification of SNPs associated with affliction and susceptibility to environmental factors. The strength of this applied science is the massive amount of easily measurable genetic variation it puts in the hands of researchers in a cost-effective manner ($500 to $1,000 per fleck). The criteria for the selection of SNPs to be included on these arrays are a critical consideration, since they affect the inferences that can be drawn from using these platforms. Of course, the ultimate tool for SNP discovery and genotyping is private whole genome sequencing. Although not currently feasible, the rapid advancement of engineering at present being stimulated by the National Human Genome Research Institute's "$i,000 genome" projection likely will make this approach the optimal one for SNP discovery and genotyping in the futurity.

With the power to examine large quantities of genetic variations, researchers are moving from investigations of single genes, one at a time, to consideration of entire pathways or physiological systems that include information from genomic, transcriptomic, proteomic, and metabonomic levels that are all discipline to different environmental factors (Haines and Pericak-Vance, 1998). However, these genome- and pathway-driven study designs and analytic techniques are still in the early stages of development and will require the joint efforts of multiple disciplines, ranging from molecular biologists to clinicians to social scientists to bioinformaticians, in order to make the near effective use of these vast amounts of data.

Factor-Surroundings AND GENE-GENE INTERACTIONS

The study of gene-environment and gene-gene interactions represents a broad class of genetic association studies focused on agreement how human being genetic variability is associated with differential responses to environmental exposures and with differential furnishings depending on variations in other genes. To illustrate the concept of gene-surround interactions, contempo studies that identify genetic mutations that appear to be associated with differential response to cigarette smoke and its association with lung cancer are reviewed below. Tobacco smoke contains a broad assortment of chemical carcinogens that may crusade Dna damage. There are several Deoxyribonucleic acid repair pathways that operate to repair this harm, and the genes inside this pathway are prime number biological candidates for understanding why some smokers develop lung cancers but others exercise not. In a study by Zhou et al. (2003), variations in two genes responsible for Deoxyribonucleic acid repair were examined for their potential interaction with the level of cigarette smoking and concomitant association with lung cancer. Briefly, i putatively functional mutation in the XRCC1 (Ten-ray cross-complementing group i) cistron and ii putatively functional mutations in the ERCC2 (excision repair cross-complementing group 2) gene were genotyped in one,091 lung cancer cases and 1,240 controls. When the cases and controls were stratified into heavy smokers versus nonsmokers, Zhou et al. (2003) establish that nonsmokers with the mutant XRCCI genotype had a 2.4 times greater hazard of lung cancer than nonsmokers with the normal genotype. In dissimilarity, heavy smokers with the mutant XRCCI genotype had a 50 per centum reduction in lung cancer risk compared to their counterparts with the more frequent normal genotype. When the 3 mutations from these two genes were examined together in the extreme genotype combination (individual with five or six mutations present in his/her genotype) in that location was a 5.two fourth dimension greater risk of lung cancer in nonsmokers and a 70 per centum reduction of adventure in the heavy smokers compared to individuals with no mutations. The protective effect of these genetic variations in heavy smokers may be caused past the differential increase in the activeness of these protective genes stimulated by heavy smoking. Similar types of gene-smoking interactions also have been found for other genes in this pathway, such as ERCC1. These studies illustrate the importance of identifying the genetic variations that are associated with the differential gamble of disease related to man behaviors. Note that this blazon of research also raises many different kinds of upstanding and social bug, since it identifies susceptible subgroups and protected subgroups of subjects past both genetic and human behavior strata (see Chapter x).

The study by Zhou et al. (2003) also demonstrates the increased data provided by jointly examining the effects of multiple mutations on toxicity-related illness. Other studies of mutations in genes involved in the Phase Ii metabolism (GSTM1, GSTT1, GSTP1) also accept demonstrated the importance of investigating the joint furnishings of mutations (Miller et al., 2002) on cancer take chances. Although these two studies focused on the additive effects of multiple genes, cistron-gene interactions are another important component to develop a better understanding of human being susceptibility to disease and to interactions with the surroundings.

To adequately understand the continuum of genomic susceptibility to ecology agents that influences the public's health, more studies of the joint effects of multiple mutations demand to be conducted. Advances in bioinformatics can play a key role in this attempt. For example, methods to screen SNP databases for mutations in transcriptional regulatory regions tin be used for both discovery and functional validation of polymorphic regulatory elements, such as the antioxidant regulatory element found in the promoter regions of many genes encoding antioxidative and Phase II detoxification enzymes (Wang et al., 2005). Comparative sequence assay methods besides are condign increasingly valuable to human genetic studies, considering they provide a ways to rank order SNPs in terms of their potential deleterious effects on protein function or factor regulation (Wang et al., 2004). Methods of performing large-calibration analysis of nonsynonymous SNPs to predict whether a particular mutation impairs protein function (Clifford et al., 2004) can help in SNP selection for genetic epidemiological studies and can be used to streamline functional analysis of mutations that are institute to be statistically associated with differential response to ecology factors such as diet, stress, and socioeconomic factors.

MECHANISMS OF GENE EXPRESSION

Identifying genes whose variations are associated with disease is but the first stride in linking genetics and health. Understanding the mechanisms by which the gene is expressed and how it is influenced by other genes, proteins, and the surroundings is condign increasingly important to the development of preventive, diagnostic, and therapeutic strategies.

When genes are expressed, the chromosomal Deoxyribonucleic acid must be transcribed into RNA and the RNA is then processed and transported to be translated into poly peptide. Regulating the expression of genes is a vital process in the cell and involves the organization of the chromosomal DNA into an appropriate higher-order chromatin structure. It also involves the action of a host of specific protein factors (to either encourage or suppress gene expression), which can act at different steps in the factor expression pathway.

In all organisms, networks of biochemical reactions and feedback signals organize developmental pathways, cellular metabolism, and progression through the cell cycle. Overall coordination of the cell cycle and cellular metabolism results from feed-forward and feedback controls arising from sets of dependent pathways in which the initiation of events is dependent on earlier events. Inside these networks, gene expression is controlled past molecular signals that regulate when, where, and how often a given gene is transcribed. These signals frequently are stimulated by environmental influences or by signals from other cells that bear upon the cistron expression of many genes through a single regulatory pathway. Since a regulatory gene can deed in combination with other signals to command many other genes, complex branching networks of interactions are possible (McAdams and Arkin, 1997).

Gene regulation is disquisitional because by switching genes on or off when needed, cells tin be responsive to changes in environment (e.g., changes in diet or activity) and can prevent resources from being wasted. Variation in the DNA sequences associated with the regulation of a gene'due south expression are therefore probable candidates for understanding factor-environment interactions at the molecular level, since these variations will impact whether an environmental indicate transduced to the nucleus will successfully bind to the promoter sequence in the factor and stimulate or repress gene expression. Combining genomic technologies for SNP genotyping with high-density gene expression arrays in human studies has but recently elucidated the extent to which this blazon of molecular cistron-environment interaction may be occurring.

Cells likewise regulate gene expression by postal service-transcriptional modification; past assuasive only a subset of the mRNAs to go along to translation; or past restricting translation of specific mRNAs to only when and where the product is needed. The genetic factors that influence postal service-transcriptional control are much more than difficult to study because they often involve multiprotein complexes non hands retrieved or assayed from cells. At other levels, cells regulate gene expression through epigenetic mechanisms, including Deoxyribonucleic acid folding, histone acetylation, and methylation (i.east., chemic modification) of the nucleotide bases. These mechanisms are probable to be influenced by genetic variations in the target genes equally well as variations manifested in translated cellular regulatory proteins. Factor regulation occurs throughout life at all levels of organismal development and aging.

A classic example of developmental command of gene expression is the differential expression of embryonic, fetal, and adult hemoglobin genes (see Box 3-1). The regulation of the epsilon, delta, gamma, alpha, and beta genes occurs through Deoxyribonucleic acid methylation that is tightly controlled through developmental signals. During development a large number of genes are turned on and off through epigenetic regulation. One of the fastest growing fields in genetics is the study of the developmental consequences of environmental exposures on factor expression patterns and the impact of genetic variations on these developmental trajectories.

BOX three-1

Factor Expression and Globin. The production of hemoglobin is regulated by a number of transcriptional controls, such as switching, that dictate the expression of a different fix of globin genes in different parts of the body throughout the various stages (more than...)

An Example of a Single-Factor Disorder with Meaning Clinical Variability: Sickle Cell Disease³

Sickle prison cell illness refers to an autosomal recessive blood disorder caused by a variant of the β-globin gene called sickle hemoglobin (Hb S). A single nucleotide commutation (T→A) in the sixth codon of the β-globin cistron results in the substitution of valine for glutamic acrid (GTG→GAG), which can crusade Hb South to polymerize (form long bondage) when deoxygenated (Stuart and Nagel, 2004). An individual inheriting two copies of Hb Due south (Hb SS) is considered to have sickle cell anemia, while an individual inheriting i copy of Hb Due south plus another deleterious β-globin variant (due east.g., Hb C or Hb β-thalassemia) is considered to have sickle cell disease. An individual is considered to be a carrier of the sickle prison cell trait if he/she has one copy of the normal β-globin gene and one re-create of the sickle variant (Hb Every bit) (Ashley-Koch et al., 2000).

Four major β-globin gene haplotypes have been identified. 3 are named for the regions in Africa where the mutations first appeared: BEN (Republic of benin), SEN (Senegal), and Automobile (Central African Republic). The quaternary haplotype, Arabic-India, occurs in India and the Arabic peninsula (Quinn and Miller, 2004).

Disease severity is associated with several genetic factors (Ashley-Koch et al., 2000). The highest caste of severity is associated with Hb SS, followed past Hb s/β0-thalassemia, and Hb SC. Hb South/β⁺-thalassemia is associated with a more benign grade of the affliction (Ashley-Koch et al., 2000). Disease severity likewise is related to β-globin haplotypes, probably due to variations in hemoglobin level and fetal hemoglobin concentrations. The Senegal haplotype is the most beneficial form, followed by the Benin, and the Central African Democracy haplotype is the most severe course (Ashley-Koch et al., 2000).

Thus, although sickle cell illness is a monogenetic disorder, its phenotypic expression is multigenic (see Appendix D). At that place are 2 cardinal pathophysiologic features of sickle jail cell illness—chronic hemolytic anemia and vasoocclusion. Two principal consequences of hypoxia secondary to vasoocclusive crisis are pain and damage to organ systems. The organs at greatest take a chance are those in which claret flow is slow, such every bit the spleen and bone marrow, or those that have a limited final arterial blood supply, including the eye, the head of the femur and the humerus, and the lung as the recipient of deoxygenated sickle cells that escape the spleen or os marrow. Major clinical manifestations of sickle prison cell disease include painful events, astute chest syndrome, splenic dysfunction, and cerebrovascular accidents.

Efforts to enhance clinical intendance are focusing on increasing our understanding of the pathophysiology of sickle cell disease in gild to facilitate a precise prognosis and individualized handling. Required is knowledge near which genes are associated with the hemolytic and vascular complications of sickle jail cell disease and how variants of these genes interact amidst themselves and with their environment (Steinberg, 2005).

ASPECTS OF HEALTH INFLUENCED BY GENETICS

Because every jail cell in the trunk, with rare exception, carries an entire genome total of variation equally the template for the development of its protein machinery, it tin can be argued that genetic variation impacts all cellular, biochemical, physiological, and morphological aspects of a human existence. How that genetic variation is associated with particular disease risk is the focus of much current research. For mutual diseases such every bit CVD, hypertension, cancer, diabetes, and many mental illnesses, there is a growing appreciation that different genes and different genetic variations tin can be involved in different aspects of their natural history. For instance, there are likely to be genes whose variations are associated with a predisposition toward the initiation of disease and other genes or gene variations that are involved in the progression of a disease to a clinically divers endpoint. Furthermore, an entirely unlike set of genes may be involved in how an individual responds to pharmaceutical treatments for that disease. There also are probable to exist genes whose variability controls how much or how fiddling a person is likely to be responsive to the environmental risk factors that are associated with disease gamble. Finally, there are idea to be genes that bear upon a person's overall longevity that may annul or collaborate with genes that may otherwise predispose that person to a item disease upshot and thus may have an additional impact on survivorship.

In many ways, we are only at the beginning the process of developing a truthful agreement of how genomic variations give rise to disease susceptibility. Indeed many would argue that, without incorporating the every bit important role of the surroundings, we volition never fully understand the role of genetics in health. As progress is made through utilizing the new technologies for measuring biological variation in the genome, transcriptome, proteome, and metabonome, nosotros are likely to have to make large shifts in our conceptual frameworks almost the roles of genes in disease. Global patterns of genomic susceptibility are probable to emerge only when nosotros consider the influence of the many interacting components working simultaneously that are dependent on contexts such every bit historic period, sex, nutrition, and physical activity that modify the relationship with hazard. For the most office, nosotros are still at the stage of documenting the complication, finding examples and types of genetic susceptibility genes, understanding affliction heterogeneity, and postulating means to develop models of risk that use the totality of what we know about human biology, from our genomes to our ecologies to model chance.

Cardiovascular Disease (CVD)

The study of CVD can be used to illustrate the issues that are encountered in using genetic information in order to understand the etiology of the most common chronic diseases as well as in identifying those at highest risk of developing these diseases. The bulk of CVD cases accept a complex multifactorial etiology, and even full knowledge of an private's genetic makeup cannot predict with certainty the onset, progression, or severity of disease (Sing et al., 2003). Disease develops as a effect of interactions betwixt a person's genotype and exposures to environmental agents, which influence cardiovascular phenotypes kickoff at formulation and continuing throughout machismo. CVD research has constitute many high-risk environmental agents and hundreds of genes, each with many variations that are idea to influence disease risk. As the number of interacting agents involved increases, a smaller number of cases of illness volition exist institute to take the same etiology and be associated with a particular genotype (Sing et al., 2003). The many feedback mechanisms and interactions of agents from the genome through intermediate biochemical and physiological subsystems with exposure to ecology agents contribute to the emergence of a given individual'southward clinical phenotype. In attempting to sort out the relative contributions of genes and surroundings to CVD, a big assortment of factors must be considered, from the influence of genes on cholesterol (e.g., LDL levels) to psychosocial factors such as stress and anger. Although hundreds of genes take been implicated in the initiation, progression, and clinical manifestation of CVD, relatively little is known about how a person's surroundings interacts with these genes to tip the balance between the atherogenic and anti-atherogenic processes that result in clinically manifested CVD. Delight see Chapters 4 and 6 for further discussion of furnishings of social surround on CVD.

It is well known that many social and behavioral factors ranging from socioeconomic status, job stress, and depression, to smoking, exercise, and diet affect cardiovascular illness take a chance (see Chapters 2, 3, and 6 for more detailed discussion of these factors). Every bit more studies of factor-environment interaction consider these factors as part of the "environs," which are examined in conjunction with genetic variations, multiple intellectual and methodological challenges arise. Beginning, how are the social factors embodied such that an interaction with a particular genotype can be associated with differential risk? 2d, how tin can we handle complex interactions to address questions, such as how does an private's genotype influence his/her beliefs? For instance, one's genetic susceptibility to nicotine addiction is actually a risk factor for CVD and its effect on CVD take chances may be contingent on interactions with other genetic factors.

Pharmacogenetics

Information technology has been well established that individuals oft respond differently to the same drug therapy. The drug disposition procedure is a complex fix of physiological reactions that brainstorm immediately upon assistants. The drug is absorbed and distributed to the targeted areas of the torso where it interacts with cellular components, such equally receptors and enzymes, that further metabolize the drug, and ultimately the drug is excreted from the torso (Weinshilboum, 2003). At any point during this process, genetic variation may alter the therapeutic response of an private and crusade an adverse drug reaction (ADR) (Evans and McLeod, 2003). Information technology has been estimated that 20 to 95 per centum of variations in drug disposition, such as ADRs, tin can be attributed to genetic variation (Kalow et al., 1998; Evans and McLeod, 2003).

Sensitivity to both dose-dependent and dose-independent ADRs can take roots in genetic variation. Polymorphisms in kinetic and dynamic factors, such as cytochrome P450 and specific drug targets tin can cause these individuals susceptibilities to ADRs. While the characteristics of the ADR dictate the truthful significance of these factors, in most cases, multiple genes are involved (Pirmohamed and Park, 2001). Hereafter analyses using genome-broad SNP profiling could provide a technique for assessing several genetic susceptibility factors for ADRs and ascertaining their joint furnishings. One of the challenges to the study of the relationship betwixt genetic variation and ADRs is an inadequate number of patient samples. To remedy this problem, Pirmohamed and Park (2001) have proposed that prospective randomized controlled clinical trials become a role of standardized exercise to ultimately prove the clinical utility of genotyping all patients as a mensurate to prevent ADRs.

Here we review some of the current work in pharmacogenetics as an example of what might exist expected to ascend from rigorous study of the interaction between social, behavioral, and genetic factors. Researchers have provided a few well-established examples of differences in individual drug response that have been ascribed to genetic variations in a variety of cellular drug disposition machinery, such as drug transporters or enzymes responsible for drug metabolism (Evans and McLeod, 2003). For example:

• With the knowledge that the HER2 gene is overexpressed in approximately one fourth of breast cancer cases, researchers developed a humanized monoclonal antibody against the HER2 receptor in hopes of inhibiting the tumor growth associated with the receptor. Genotyping advanced breast cancer patients to identify those with tumors that overexpress the HER2 receptor has produced promising results in improving the clinical outcomes for these breast cancer patients (Cobleigh et al., 1999).

• A therapeutic class of drugs called thiopurines is used as office of the handling regimen for babyhood acute lymphoblastic leukemia. One in 300 Caucasians has a genetic variation that results in low or nonexistent levels of thiopurine methyltransferase (TPMT), an enzyme that is responsible for the metabolism of the thiopurine drugs. If patients with this genetic variation are given thiopurines, the drug accumulates to toxic levels in their trunk causing life-threatening myelosuppression. Assessing the TPMT phenotype and genotype of the patient can be used to determine the individualized dosage of the drug (Armstrong et al., 2004).

• The family of liver enzymes called cytochrome P450s plays a major function in the metabolism of as many as 40 different types of drugs. Genetic variants in these enzymes may diminish their power to finer break down certain drugs, thus creating the potential for overdose in patients with less active or inactive forms of the cytochrome P450 enzyme. Varying levels of reduced cytochrome P450 activity is also a concern for patients taking multiple drugs that may interact if they are not properly metabolized past well-functioning enzymes. Strategies to evaluate the action level of cytochrome P450 enzymes have been devised and are valuable in planning and monitoring successful drug therapy. Some pharmaceutical drug trials are now incorporating early on tests that evaluate the ability of differing forms of cytochrome P450 to metabolize the new drug compound (Obach et al., 2006).

Some pharmacogenetics research has focused on the handling of psychiatric disorders. With the introduction of a class of drugs known as selective serotonin re-uptake inhibitors (SSRIs), pharmacological treatment of many psychiatric disorders changed drastically. SSRIs offer meaning improvements over the previous generation of treatments, including improved efficacy and tolerance for many patients. Even so, not all patients respond positively to SSRI treatment and many experience ADRs. New pharmacogenetic studies have indicated that these ADRs may be the result of genetic variations in serotonin transporter genes and cytochrome P450 genes. Further study and replication of these findings are necessary. If the characterization of the genetic variations is completed and is fully understood information technology would exist possible to screen and monitor patients using genotyping techniques to create individualized drug therapies similar to those discussed higher up (Mancama and Kerwin, 2003).

A pregnant claiming to the development of individualized drug therapies is the often polygenic or multifactorial inherited component of drug responses. Isolating the polygenic determinants of the drug responses is a sizable task. A expert understanding of the drug's mechanism of action and metabolic and disposition pathways should exist the ground of all investigations. This knowledge tin can assist in directing genome-wide searches for gene variations associated with drug furnishings and subsequent candidate-gene approaches of investigation. Additionally, proteomic and gene-expression profiling studies are also of import ways to substantiate and understand the pathways by which the gene of interest operates to affect the private's response to the drug (Evans and McLeod, 2003). It is non plenty to evidence an association; characterization of the underlying biological mechanisms is an essential component of moving genetic findings into the area of take chances reduction. Some other key component of utilizing genetics to amend prevention and reduce disease is an agreement of the distribution of the genetic variations in the populations being served.

GENETICS OF POPULATONS AS RELATED TO HEALTH AND Disease

Human populations differ in their distribution of genetic variations. This is a outcome of their historical patterns of mutation, migration, reproduction, mating, option, and genetic drift. Inherited mutations typically occur during gametogenesis within a single individual so can be passed on to offspring for many generations. Whether that mutation goes on to get a prevalent polymorphism (i.e., a mutation with a population frequency of greater than 1 pct) is determined past both evolutionary forces and chance events. For instance, information technology depends on whether the original kid who inherited the mutation survives to adulthood and reproduces and whether that child'due south children survive to reproduce, and and then on. The number of children in a family unit also influences the prevalence of the mutation, and this is oft tied to environmental factors that impact fertility and mating patterns that influence the speed with which a private mutation becomes a public polymorphism. There are well-known examples of what are chosen founder mutations in which this trajectory tin be documented. For case, i detail commune in what is Quebec (Canada) today was originally founded past only a few families from a item French province. One of the founding fathers carried a 10kb deletion in his LDL receptor (LDL-R) gene that was passed down through the generations quickly and today is carried by one in 154 French Canadians in northeastern Quebec. This mutation is associated with familial hypercholesterolemia, and French Ca nadians accept one of the highest prevalences of this illness in the earth because of the small founding populations followed past population expansion (Moorjani et al., 1989).

In that location are also a number of examples where mutations that arise in an private go more prevalent because of the selective reward they impart on their carriers. The all-time known instance is the mutation associated with sickle cell anemia. The geographical pattern of this mutation strongly mirrors the geographical pattern of malarial infection. It has been molecularly demonstrated that individuals carrying the sickle prison cell mutation have a resistance to malarial infection. Because many of the selection pressures that may take given ascension to the current distribution of mutations in item populations are in our evolutionary past, it is difficult to assess how much variation within or among populations is due to these types of selection forces.

Another major strength in determining the distribution of genetic variations within and among human populations is their migration and reproductive isolation. According to our best cognition, one of the near of import periods in human evolution occurred approximately 100,000 years ago, when some humans migrated to other continents from the African basin and established new communities with relative reproductive isolation. Genetic differences among people in different geographical areas take been associated with the concept of race for hundreds of years. Although race is nonetheless used as a characterization, the original concept of race as genetically distinct subspecies of humans has been rejected through modern genetic information. For numerous reasons, discussed in the section below, information technology is more than appropriate to reconceptualize the old genetics of race into a more than authentic genetics of ancestry.

In addition to distant evolutionary patterns of migration, more mod migration patterns too have had a profound consequence on the genetics of populations. For example, the current population of the United States and much of North America is very various genetically every bit a consequence of the mixing of many people from many different countries and continents.

A central reason for studying the origins and nature of human genetic variation is that the similarities and differences in the type and frequencies of genetic variations within and among populations can have a profound bear upon on studies that endeavour to understand the influence of genes on illness risk. For case, some genetic variations, such as the apolipoprotein E poly peptide polymorphisms, are found in every population and take very similar genotype frequencies around the earth (Wu et al., 2002; Deniz Naranjo et al., 2004). The variation's association with increased center disease and Alzheimer's disease could exist and has been tested in many of the world's populations. Other mutations such as the 10kb deletion in the LDL-R gene described above are more than population-specific variations.

Furthermore, from a statistical indicate of view, the outcome of a genetic variation on the continuum of risk found in any population is correlated with its frequency. For example, common genetic polymorphisms with frequencies well-nigh l percent cannot be associated with big phenotypic effects within a population considering the genotype classes each stand for a large fraction of the population and, since most risk is normally distributed, the average risk for a highly prevalent genotype class cannot deviate from the overall risk of the population to any large degree. This correlation between genotype frequency and result does not mean that common variations cannot exist significant in their furnishings. The statistical significance of an clan betwixt a genetic variant and a illness is a joint function of sample size and the size of the effect. In addition, genetic research amid populations that differ in their genotype frequencies can differ in their inferences well-nigh which polymorphisms have significant furnishings even if the absolute phenotypic effect is the same. Meet Cheverud and Routman (1995) for a more than formal statistical explanation of this miracle and its impact on assessing gene-gene interactions.

Another key consideration in understanding the relationship between genetic variations and measures of illness adventure is the population differences in the correlations betwixt genotype frequencies at different SNP locations. There are 2 common reasons why the frequency of an allele or genotype at a item SNP could exist correlated with the frequency of an allele or genotype for a different SNP. Outset, a miracle known as linkage disequilibrium creates correlations among SNPs every bit a result of the mutation's history. When mutations arise, they occur on a item genetic background, which creates a correlation with the other SNPs on the chromosome. Second, the mixing of populations known as admixture that occurs typically through migration ways that SNPs with population-specific frequencies will be correlated in a larger mixed sample. In this case, population stratification is the cause of the correlation, and there has been much genetic epidemiological research on this phenomenon and how to command for information technology. Population stratification is idea to be a possible source of spurious genetic associations with disease (see Box 3-2).

BOX 3-2

Population Stratification (Confounding). When the gamble of disease varies betwixt two ethnic groups, any genetic or environmental factor that also varies between the groups will appear to be related to disease. This phenomenon is chosen "population (more than...)

CONCLUSION

In large part, the twentieth century was dominated by studies of human health and disease that focused on identifying single genetic and environmental agents that could explicate variation in illness susceptibility. This new century has been characterized by huge advances in our understanding of Mendelian disorders with severe clinical outcomes. However, the Men delian image has failed to elucidate the genetic contribution to susceptibility to most common chronic diseases, which researchers know have a substantial genetic component because of their familial assemblage and studies that demonstrate significant heritabilities for these diseases. Likewise, environmental and social epidemiological studies accept been wildly successful in illuminating the role of many ecology factors such as diet, exercise, and stress on disease gamble. However, these environmental factors still do not, by themselves, fully explain the variance in the prevalence of several diseases in different populations. Researchers are only now start to study in earnest the potential interactions betwixt the genetic and environmental factors that are likely to be contributing to a large fraction of disease in most populations. At that place is much that can be done to incorporate measures of social surroundings into genetic studies and to also incorporate genetic measures into social epidemiological studies.

Over the terminal two decades, progress in identifying specific genes and mutations that explain genetic susceptibility to common conditions has been relatively dull, for a variety of reasons. First, the diseases being studied tend to be complex in their etiology, meaning that dissimilar people in a population will develop disease for different genetic and/or environmental reasons. Whatsoever unmarried genetic or environmental factor is expected to explain only a very minor fraction of disease risk in a population. Moreover, these factors are expected to interact, and other biological processes (east.g., epigenetic modifications) are probable to be contributors to the circuitous puzzle of susceptibility. An authentic phenotypic definition of disease and its subtypes is crucial to identifying and understanding the complexities of affliction-specific genetic and environmental causes.

Second, geneticists just recently have adult the knowledge base or methods needed to measure out genetic variations and their metabolic consequences with sufficient ease and price-effectiveness and so that the large number of genes thought to be involved can be studied. With the completion of the Human Genome Projection in 2003, many dissimilar scientific entities (e.g., the Ecology Genome Projection and the International HapMap Consortium) take been working to identify the mutational spectra in human populations, and genetic epidemiologists are just now beginning to understand the extensive nature of common variations (>one percent population frequency) inside the human being genome that could be affecting people's risk of disease. The SNP data generated by these initiatives are now centrally located in a number of public databases, including the National Eye for Biotechnology Data's dbSNPs database, the National Cancer Institute's CGAP Genetic Annotation Initiative SNP Database, and the Karolinska Institute Human Genic Bi-Allelic Sequences Database. At present, the largest dataset on man variation is beingness generated by the International HapMap Projection,⁴ which is genotyping millions of SNPs on 270 individuals from 4 geographically separated sites from around the world. The International HapMap Project has greatly increased the number of validated SNPs bachelor to the enquiry community to be used to study human variation and is producing a map of genomic haplotypes in four populations with ancestry from parts of Africa, Asia, and Europe. In addition, high-throughput methods of genotyping large numbers of SNPs (thousands) in big epidemiological cohorts are only at present becoming bachelor (come across above). Unfortunately, high-throughput methods of measuring the surround have not kept a similar stride. For many studies of common disease, a rate-limiting step to increasing our understanding volition continue to be the hard and costly measurement of ecology factors.

Finally, progress too has been hampered because of a lack of adequate investment in developing new methods of analysis that can incorporate the high-dimensional biological reality that we can now measure. The complex genetic and environmental architecture of multifactorial diseases is not hands detected or deciphered using the traditional statistical modeling methods that are focused on the estimation of a single overall model of disease for a population. For example, using traditional logistic regression methods it would exist simply impossible to enter all the hundreds of genetic variations that are thought to exist involved in CVD risk or in any of the other common disease complexes currently being studied. Beyond the obvious issues of power and overdetermination in such a big-scale model, we also do not know how to model or interpret interactions amongst many factors simultaneously or how to incorporate the rare, large effects of some genes relative to the common, pocket-sized effects of others. New modeling strategies that take advantage of advances in pattern recognition, automobile learning, and systems analysis (e.thou., scale-free networks, Bayesian conventionalities networks, random wood methods) are going to exist needed in order to build more than comprehensive, predictive models of these etiologically heterogeneous diseases.

The field of man genetics, similar many other disciplines, is in transition, and in that location is much to be gained past joining forces with a wide range of other disciplines that are focused on improving prevention and reducing the illness burden in our populations.

REFERENCES

1. Altshuler D, Kruglyak L, Lander E. Genetic polymorphisms and illness. New England Journal of Medicine. 1998;338(22):1626. [PubMed: 9606122]

2. Ardlie KG, Lunetta KL, Seielstad Yard. Testing for population subdivision and clan in 4 example-control studies. American Periodical of Human being Genetics. 2002;71(2):304–311. [PMC free article: PMC379163] [PubMed: 12096349]

3. Armstrong VW, Shipkova G, von Ahsen Due north, Oellerich M. Analytic aspects of monitoring therapy with thiopurine medications. Therapeutic Drug Monitoring. 2004;26(ii):220–226. [PubMed: 15228169]

4. Ashley-Koch A, Yang Q, Olney R. Sickle hemoglobin (Hb S) allele and sickle prison cell illness: A HuGE review. American Journal of Epidemiology. 2000;151(ix):839–845. [PubMed: 10791557]

6. Chocolate-brown MS, Goldstein JL. Lowering plasma cholesterol by raising LDL receptors. New England Periodical of Medicine. 1981;305(9):515–517. [PubMed: 6265781]

7. Cardon LR, Bong JI. Association study designs for complex diseases. Nature Reviews Genetics. 2001;2(ii):91–99. [PubMed: 11253062]

9. Clifford RJ, Edmonson MN, Nguyen C, Buetow KH. Large-calibration analysis of non-synonymous coding region single nucleotide polymorphisms. Bioinformatics. 2004;twenty(7):1006–1014. [PubMed: 14751981]

10. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak Southward, Lieberman G, Slamon DJ. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who take HER2-overexpressing metastatic chest cancer that has progressed subsequently chemotherapy for metastatic disease. Periodical of Clinical Oncology. 1999;17(9):2639–2648. [PubMed: 10561337]

11. Deniz Naranjo MC, Munoz Fernandez C, Alemany Rodriguez MJ, Perez Vieitez MC, Irurita Latasa J, Suarez Armas R, Suarez Valentin MP, Sanchez Garcia F. Gender has a stiff modulating outcome on the risk of Alzheimer's disease conferred by the apolipoprotein E factor in the population of the Canary Islands, Spain. Revista de Neurologia. 2004;38(vii):615–618. [PubMed: 15098180]

12. Evans WE, McLeod HL. Pharmacogenomics—drug disposition, drug targets, and side furnishings. New England Journal of Medicine. 2003;348(6):538–549. [PubMed: 12571262]

13. Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS. A genome-wide scalable SNP genotyping assay using microarray technology. Nature Genetics. 2005;37(v):549–554. [PubMed: 15838508]

14. Haines JL, Pericak-Vance MA. Approaches to Cistron Mapping in Complex Man Diseases. New York: Wiley-Liss; 1998.

15. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. Linkage of early-onset familial breast cancer to chromosome 17q21. Scientific discipline. 1990;250(4988):1684–1689. [PubMed: 2270482]

16. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin Eastward, Ballinger DG, Frazer KA, Cox DR. Whole-genome patterns of common Dna variation in three human populations. Science. 2005;307(5712):1072–1079. [PubMed: 15718463]

17. IOM (Institute of Medicine). Implications of Genomics for Public Health. Washington, DC: The National Academies Press; 2005.

18. Kalow Westward, Tang BK, Endrenyi L. Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug enquiry. Pharmacogenetics. 1998;8(4):283–289. [PubMed: 9731714]

19. Kardia SL, Modell SM, Peyser PA. Family-centered approaches to understanding and preventing coronary centre affliction. American Journal of Preventive Medicine. 2003;24(2):143–151. [PubMed: 12568820]

20. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308(5720):385–389. [PMC costless article: PMC1512523] [PubMed: 15761122]

21. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265(5181):2037–2048. [PubMed: 8091226]

22. Livingston RJ, von Niederhausern A, Jegga AG, Crawford DC, Carlson CS, Rieder MJ, Gowrisankar S, Aronow BJ, Weiss RB, Nickerson DA. Blueprint of sequence variation beyond 213 environmental response genes. Genome Inquiry. 2004;14(10A):1821–1831. [PMC free article: PMC524406] [PubMed: 15364900]

23. Mancama D, Kerwin RW. Office of pharmacogenomics in individualising handling with SSRIs. CNS Drugs. 2003;17(3):143–151. [PubMed: 12617694]

24. Mathew C. Scientific discipline medicine and the time to come—postgenomic technologies: Hunting the genes for mutual disorders. British Medical Journal. 2001;322(7293):1031–1034. [PMC complimentary article: PMC1120184] [PubMed: 11325769]

25. McAdams HH, Arkin A. Stochastic mechanisms in gene expression. Proceedings of the National University of Sciences of the United States of America. 1997;94(3):814–819. [PMC free commodity: PMC19596] [PubMed: 9023339]

26. Miller DP, Liu Yard, De Vivo I, Lynch TJ, Wain JC, Su 50, Christiani DC. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer chance. Cancer Inquiry. 2002;62(10):2819–2823. [PubMed: 12019159]

27. Moorjani South, Roy Yard, Gagne C, Davignon J, Brun D, Toussaint One thousand, Lambert M, Campeau 50, Blaichman S, Lupien P. Homozygous familial hypercholesterolemia among French Canadians in Quebec Province. Arteriosclerosis. 1989;9(ii):211–216. [PubMed: 2923577]

28. Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions. Journal of Pharmacology and Experimental Therapeutics. 2006;316(ane):336–348. [PubMed: 16192315]

29. Pirmohamed M, Park BK. Genetic susceptibility to agin drug reactions. Trends in Pharmacological Sciences. 2001;22(six):298–305. [PubMed: 11395158]

30. Pritchard JK, Rosenberg NA. Apply of unlinked genetic markers to detect population stratification in clan studies. American Journal of Human Genetics. 1999;65(ane):220–228. [PMC free commodity: PMC1378093] [PubMed: 10364535]

31. Quinn CT, Miller ST. Chance factors and prediction of outcomes in children and adolescents who take sickle cell anemia. Hematology/Oncology Clinics of North America. 2004;18(6 SPEC.ISS):1339–1354. [PubMed: 15511619]

32. Rebbeck TR, Walker AH, Phelan CM, Godwin AK, Buetow KH, Garber JE, Narod SA, Weber BL. Defining etiologic heterogeneity in breast cancer using genetic biomarkers. Progress in Clinical and Biological Inquiry. 1997;396:53–61. [PubMed: 9108589]

33. Rimoin DL, Connor JM, Pyeritz RE, Korf BR, editors. Emery and Rimoin'south Principles and Practise of Medical Genetics. 4th edition. Vol. two. New York: Churchill Livingstone; 2002.

34. Risch NJ. Searching for genetic determinants in the new millennium. Nature. 2000;405(6788):847–856. [PubMed: 10866211]

35. Satten GA, Flanders WD, Yang Q. Accounting for unmeasured population substructure in case-control studies of genetic clan using a novel latent-class model. American Journal of Human Genetics. 2001;68(two):466–477. [PMC free article: PMC1235279] [PubMed: 11170894]

36. Sing CF, Stengard JH, Kardia SLR. Genes, environment, and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1190–1196. [PubMed: 12730090]

37. Smith Chiliad. The Genomics Historic period: How DNA Technology Is Transforming the Way We Live and Who We Are. New York: AMACOM; 2005.

38. Steinberg MH. Predicting clinical severity in sickle cell anaemia. British Journal of Haematology. 2005;129(4):465–481. [PubMed: 15877729]

39. Stuart MJ, Nagel RL. Sickle-prison cell disease. Lancet. 2004;364(9442):1343–1360. [PubMed: 15474138]

40. Syvanen Ac. Toward genome-wide SNP genotyping. Nature Genetics. 2005;(37 Suppl):S5–S10. [PubMed: 15920530]

41. Thompson MW, McInnes RR, Willard, editors. Thompson & Thompson Genetics in Medicine. 5th edition. Philadelphia, PA: W.B. Saunders Company; 1991.

42. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias. Journal of the National Cancer Plant. 2000;92(fourteen):1151–1158. [PubMed: 10904088]

43. Wang X, Tomso DJ, Liu X, Bell DA. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicology and Applied Pharmacology. 2005;207(2 Suppl):84–90. [PubMed: 16002116]

44. Wang Z, Fan H, Yang HH, Hu Y, Buetow KH, Lee MP. Comparative sequence analysis of imprinted genes between human and mouse to reveal imprinting signatures. Genomics. 2004;83(three):395–401. [PubMed: 14962665]

45. Weinshilboum R. Inheritance and drug response. New England Journal of Medicine. 2003;348(half-dozen):529–537. [PubMed: 12571261]

46. Wu JH, Lo SK, Wen MS, Kao JT. Characterization of apolipoprotein E genetic variations in Taiwanese association with coronary heart disease and plasma lipid levels. Man Biology. 2002;74(ane):25–31. [PubMed: 11931577]

47. Zhou Due west, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Polymorphisms in the Deoxyribonucleic acid repair genes XRCC1 and ERCC2, smoking, and lung cancer take a chance. Cancer Epidemiology, Biomarkers and Prevention. 2003;12(four):359–365. [PubMed: 12692111]

1

An SNP is the DNA sequence variation that occurs when a single nucleotide (A, T, C, or G) in the genome sequence is altered (Smith, 2005).

2

A candidate gene is a gene whose protein product is involved in the metabolic or physiological pathways associated with a item disease (IOM, 2005).

3

The sickle cell example is abstracted from a commissioned paper prepared by Robert J. Thompson, Jr., Ph.D. (Appendix D).

4

Source: https://www.ncbi.nlm.nih.gov/books/NBK19932/

Posted by: tothruital.blogspot.com

Share this post